Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 10:30 a.m. ET.
Related news for (RLAY)
- Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
- Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
- Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
- 24/7 Market News Snapshot 11 December, 2024 – Relay Therapeutics, Inc. Common Stock (NASDAQ:RLAY)
- Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival